Literature DB >> 8236105

Low molecular weight heparin.

J Hirsh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8236105

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  16 in total

1.  Prophylaxis for venous thromboembolism in hip fracture surgery: total costs and cost effectiveness in The Netherlands.

Authors:  W E Mol; T C Egberts
Journal:  Pharmacoeconomics       Date:  1994-01       Impact factor: 4.981

2.  Thrombotic reactant markers in non-ST segment elevation acute coronary syndromes treated with either enoxaparin (low molecular weight heparin) or unfractionated heparin.

Authors:  E Gurfinkel; E Duronto; C Colorio; G Bozovich; M Cohen; B Mautner
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

3.  Long-term use of low-molecular-weight heparin in a patient with Heartware BIVAD (HVAD) with underlying sustained ventricular fibrillation.

Authors:  Rahul Chandola; Holger Buchholz; Roderick Macarthur
Journal:  J Cardiol Cases       Date:  2016-09-07

4.  Effects of Intravenous Enoxaparin and Intravenous Inogatran in an Electrolytic Injury Model of Venous Thrombosis in the Dog.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-11       Impact factor: 2.300

Review 5.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

6.  [Heparin-induced thrombocytopenia with unfractionated heparin. A prospective study of inpatient treatment of internal medicine patients].

Authors:  H Heidrich; K Kahl; C Penninger; B Bechstein; M Birkenmaier; S Dressler; C Fahrig; J Helmis; G Herman; U von Knobloch; M Ladleif; K Meier; M Rudolph; B Schlich; M Wanke; B Zwernemann
Journal:  Med Klin (Munich)       Date:  1998-06-15

Review 7.  Prophylaxis of venous thromboembolism in brain tumor patients.

Authors:  M G Hamilton; R D Hull; G F Pineo
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 8.  Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.

Authors:  Lara A Kahale; Charbel F Matar; Ibrahim Tsolakian; Maram B Hakoum; Victor Ed Yosuico; Irene Terrenato; Francesca Sperati; Maddalena Barba; Lisa K Hicks; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2021-09-28

Review 9.  Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.

Authors:  Lara A Kahale; Maram B Hakoum; Ibrahim G Tsolakian; Charbel F Matar; Irene Terrenato; Francesca Sperati; Maddalena Barba; Victor Ed Yosuico; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2018-06-19

Review 10.  Parenteral anticoagulation in ambulatory patients with cancer.

Authors:  Elie A Akl; Lara A Kahale; Maram B Hakoum; Charbel F Matar; Francesca Sperati; Maddalena Barba; Victor E D Yosuico; Irene Terrenato; Anneliese Synnot; Holger Schünemann
Journal:  Cochrane Database Syst Rev       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.